| 2-NBDG | 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose |
| BBD | Box–Behnken Design |
| DCFH-DA | 2′,7′-Dichlorodihydrofluorescein diacetate |
| DOTAP | 1,2-Dioleoyloxy-3-trimethylammonium propane chloride |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| FRAP | Ferric Reducing Antioxidant Power |
| MD | Mean Diameter |
| mg GAE/g | milligrams of Gallic Acid Equivalents per gram of dry extract |
| mg TE/g | milligrams of Trolox Equivalents per gram of dry extract |
| MTT | 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide |
| NAC | N-acetyl-L-cysteine |
| OE | Optimized olive leaf extract |
| OE Eu-LIP | Optimized olive leaf extract in Eu-liposomes |
| OE sol | Optimized olive leaf extract in solution |
| P90G | Phospholipon® 90G |
| PBS | Phosphate Buffered Saline |
| PI | Polydispersity Index |
| RSM | Response Surface Methodology |
| SGF | Simulated Gastric Fluid |
| SIF | Simulated Intestinal Fluid |
| T2DM | Type 2 diabetes mellitus |
| TPC | Total Phenolic Content |
| TPTZ | 2,4,6-Tripyridyl-s-triazina |
| Trolox | 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
| USP | United States Pharmacopoeia |
| ZP | Zeta Potential |